Sign Up to like & get
recommendations!
1
Published in 2023 at "ERJ Open Research"
DOI: 10.1183/23120541.00535-2022
Abstract: For people with cystic fibrosis (pwCF), gaining access to elexacaftor/tezacaftor/ivacaftor (ETI) therapy, a new modulator drug combination, is perceived as a positive life event. ETI leads to a strong improvement of disease symptoms. However, some…
read more here.
Keywords:
eti therapy;
people cystic;
rise study;
therapy ... See more keywords